Table 2. Overall study results.

Variables		Doxazosin	Placebo	P value
Daytime Frequency
	First 2 weeks	2.18 ±1.80	2.68 ± 2.00	0.028
	Second 2 weeks	1.98 ±1.64	2.48 ±1.81	0.038
	Post-stent	1.08 ±1.24	1.33 ±1.41	0.266
Nocturia
	First 2 weeks	1.35 ±1.46	1.88 ±1.74	0.021
	Second 2 weeks	1.05 ±1.18	1.66 ±1.62	0.008
	Post-stent	0.42 ± 0.83	0.49 ± 0.90	0.749
Urgency
	First 2 weeks	1.33 ±1.67	1.93 ±1.74	0.012
	Second 2 weeks	1.13 ±1.33	1.67 ±1.57	0.014
	Post-stent	0.68 ±1.26	0.77 ± 0.97	0.083
Urge incontinence
	First 2 weeks	0.09 ± 0.32	0.14 ±0.46	0.676
	Second 2 weeks	0.06 ± 0.23	0.08 ± 0.27	0.510
	Post-stent	0.00	0.02 ±0.14	0.232
Hematuria
	First 2 weeks	1.20 ±1.62	1.26 ±1.52	0.644
	Second 2 weeks	0.86 ±1.28	1.05 ±1.25	0.141
	Post-stent	0.27 ± 0.56	0.16 ±0.43	0.196
Flank pain
	First 2 weeks	1.13 ±1.46	1.83 ±1.92	0.007
	Second 2 weeks	0.93 ±1.18	1.45 ±1.54	0.014
	Post-stent	0.18 ±0.55	0.31 ± 0.67	0.140
Abdominal pain
	First 2 weeks	1.03 ±1.30	1.60 ±1.74	0.015
	Second 2 weeks	0.80 ±1.08	1.50 ±1.55	0.001
	Post-stent	0.13 ±0.39	0.29 ± 0.66	0.074
Urethral pain
	First 2 weeks	1.07 ±1.33	1.45 ±1.82	0.236
	Second 2 weeks	0.72 ±1.02	1.27 ±1.56	0.021
	Post-stent	0.18 ±0.54	0.21 ± 0.52	0.610
QoL
	First 2 weeks	2.79 ±1.05	3.27 ±1.32	0.003
	Second 2 weeks	2.69 ± 0.97	3.00 ±1.07	0.024
	Post-stent	1.44 ±0.95	1.57 ±0.69	0.273
Analgesics use
	First 2 weeks	0.30 ± 0.79	0.74 ±1.29	0.005
	Second 2 weeks	0.20 ± 0.62	0.53 ±1.02	0.006

Values in both treatment groups are presented by mean ± standard deviation

Mann-Whitney U test was used for all statistical analyses.